$FZMD
Fuse Medical, Inc.

2017 Q3 Form 10-Q Financial Statement

#000156459018029287 Filed on November 13, 2018

View on sec.gov

Income Statement

Concept 2017 Q3
Revenue $428.2K
YoY Change 298.02%
Cost Of Revenue $3.270M
YoY Change 7587.61%
Gross Profit $2.740M
YoY Change 4112.27%
Gross Profit Margin 639.88%
Selling, General & Admin $2.180M
YoY Change 1182.35%
% of Gross Profit 79.56%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $384.00
YoY Change -89.03%
% of Gross Profit 0.01%
Operating Expenses $2.190M
YoY Change 1102.41%
Operating Profit $38.07K
YoY Change -132.52%
Interest Expense $6.806K
YoY Change -78.61%
% of Operating Profit 17.88%
Other Income/Expense, Net
YoY Change
Pretax Income $510.0K
YoY Change -563.64%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $31.27K
YoY Change -128.42%
Net Earnings / Revenue 7.3%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 15.89M
Diluted Shares Outstanding 17.05M

Balance Sheet

Concept 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $470.0K
YoY Change 683.33%
Cash & Equivalents $862.2K
Short-Term Investments
Other Short-Term Assets $20.00K
YoY Change 100.0%
Inventory $10.00K
Prepaid Expenses
Receivables $290.0K
Other Receivables $0.00
Total Short-Term Assets $790.0K
YoY Change 558.33%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00
YoY Change -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $10.00K
YoY Change -50.0%
TOTAL ASSETS
Total Short-Term Assets $790.0K
Total Long-Term Assets $10.00K
Total Assets $800.0K
YoY Change 471.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $170.0K
YoY Change 41.67%
Accrued Expenses $100.0K
YoY Change 900.0%
Deferred Revenue
YoY Change
Short-Term Debt $150.0K
YoY Change 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $420.0K
YoY Change 10.53%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $420.0K
Total Long-Term Liabilities $0.00
Total Liabilities $420.0K
YoY Change 10.53%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $380.0K
YoY Change
Total Liabilities & Shareholders Equity $800.0K
YoY Change 471.43%

Cashflow Statement

Concept 2017 Q3
OPERATING ACTIVITIES
Net Income $31.27K
YoY Change -128.42%
Depreciation, Depletion And Amortization $384.00
YoY Change -89.03%
Cash From Operating Activities $410.0K
YoY Change -356.25%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -250.0K
YoY Change -350.0%
NET CHANGE
Cash From Operating Activities 410.0K
Cash From Investing Activities 0.000
Cash From Financing Activities -250.0K
Net Change In Cash 160.0K
YoY Change -366.67%
FREE CASH FLOW
Cash From Operating Activities $410.0K
Capital Expenditures $0.00
Free Cash Flow $410.0K
YoY Change -356.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Net Income Loss
NetIncomeLoss
595443
us-gaap Cost Of Revenue
CostOfRevenue
10863222
us-gaap Gross Profit
GrossProfit
8040826
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2807189
fzmd Commissions
Commissions
4558234
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5367
us-gaap Depreciation
Depreciation
12445
us-gaap Operating Expenses
OperatingExpenses
7372501
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
43308
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-72882
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
595443
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-505742
us-gaap Profit Loss
ProfitLoss
-2073082
us-gaap Share Based Compensation
ShareBasedCompensation
696843
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
63097
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11601
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-157747
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1601638
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
862184
us-gaap Interest Paid Net
InterestPaidNet
96375
fzmd Common Control Contribution Of Inventory
CommonControlContributionOfInventory
2063742
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
482000
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
482000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
57458
CY2017Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
25792
CY2017Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
0
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2945
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.98
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the condensed consolidated financial statements in accordance with GAAP, requires the Company&#8217;s management to make estimates and assumptions that affect the Company&#8217;s reported amounts in the condensed consolidated financial statements.&nbsp;&nbsp;Actual results could differ from those estimates. Significant estimates on the accompanying condensed consolidated financial statements include the allowances for doubtful accounts and contractual pricing, valuation of inventories, the useful lives of intangible assets and the recoverability or impairment of tangible and intangible assets values, fair value measurements, contingent commissions related to the sale of the Company&#8217;s products (see Note 1, &#8220;Nature of Operations &#8211; Inventories&#8221;), valuation of net assets acquired, the Company&#8217;s effective income tax rate, and the recoverability of deferred tax assets, which are based upon the Company&#8217;s management expectation of future taxable income and allowable deductions and the fair value calculations of stock-based compensation and contingent liabilities.</p></div>
CY2017Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
40342
CY2017Q4 fzmd Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
81927
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Reclassification</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain amounts in the accompanying condensed consolidated statements of operations have been reclassified to conform to the current presentation. State income tax expense has been reclassified from selling, general, administrative and other expenses to income tax expense (benefit).</p></div>
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2018Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
248838
CY2018Q3 fzmd Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
635528
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0
CY2018Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2018Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
635528
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.01
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
11.11
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.81
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.20
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y8M12D
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1717000
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2018Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2017Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2018Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2018Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
322693
CY2017Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
537388
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
84273
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
62944
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26960
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20715
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10065
us-gaap Description Of Possible Effects Of Noncompliance Or Less Than Minimum Net Worth Capital Requirements
DescriptionOfPossibleEffectsOfNoncomplianceOrLessThanMinimumNetWorthCapitalRequirements
The Company was not in compliance with the minimum quarterly net income requirement of $700,000
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
20195
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
20195
CY2018Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
6805
CY2017Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
6805
us-gaap Loss Contingency Lawsuit Filing Date
LossContingencyLawsuitFilingDate
January 27, 2014
us-gaap Loss Contingency Name Of Plaintiff
LossContingencyNameOfPlaintiff
M. Richard Cutler and Cutler Law Group, P.C.
us-gaap Loss Contingency Name Of Defendant
LossContingencyNameOfDefendant
Fuse Medical, LLC, Alan Meeker, Rusty Shelton, Jonathan Brown, Robert H. Donehew and GolfRounds.com, Inc.
us-gaap Loss Contingency Date Of Dismissal
LossContingencyDateOfDismissal
2014-04-21
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1302052
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3630000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
515000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2052
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4415000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1330000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.20
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.06
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
0
fzmd Income Tax Expense Benefit Net Of Current State Tax
IncomeTaxExpenseBenefitNetOfCurrentStateTax
-505742
fzmd Income Tax Expense Benefit Net Of Current State Tax
IncomeTaxExpenseBenefitNetOfCurrentStateTax
0
CY2018Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
342402
CY2018Q3 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
0
CY2018Q3 fzmd Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
121355
CY2018Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
203795
CY2018Q3 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
216814
CY2018Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
884366
CY2018Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
239960
CY2018Q3 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
0
CY2018Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
8878
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2945
CY2017Q4 fzmd Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
375278
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-308026
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
375278
CY2017 fzmd Increase Decrease In Deferred Tax Asset
IncreaseDecreaseInDeferredTaxAsset
260250
CY2018Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1630486
fzmd Net Operating Loss Carryforwards Earliest Expiration Year
NetOperatingLossCarryforwardsEarliestExpirationYear
2018
fzmd Net Operating Loss Carryforwards Latest Expiration Year
NetOperatingLossCarryforwardsLatestExpirationYear
2037
us-gaap Open Tax Year
OpenTaxYear
2015 2016 2017
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.010
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.026
fzmd Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.004
fzmd Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.033
us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.000
us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.383
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.196
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.026
CY2018Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
0
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
753000
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
547000

Files In Submission

Name View Source Status
0001564590-18-029287-index-headers.html Edgar Link pending
0001564590-18-029287-index.html Edgar Link pending
0001564590-18-029287.txt Edgar Link pending
0001564590-18-029287-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
fzmd-10q_20180930.htm Edgar Link pending
fzmd-20180930.xml Edgar Link completed
fzmd-20180930.xsd Edgar Link pending
fzmd-20180930_cal.xml Edgar Link unprocessable
fzmd-20180930_def.xml Edgar Link unprocessable
fzmd-20180930_lab.xml Edgar Link unprocessable
fzmd-20180930_pre.xml Edgar Link unprocessable
fzmd-ex311_8.htm Edgar Link pending
fzmd-ex312_6.htm Edgar Link pending
fzmd-ex321_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending